Form 4: Mueller Industries Executive Acquires 9,000 Shares of Common Stock

Sentiment:

SEC Form 4 Filing


Christopher John Miritello, EVP, Gen. Counsel, and Secretary of Mueller Industries, acquired 9,000 shares of common stock on August 5, 2024.

Summary

  • On August 5, 2024, Christopher John Miritello, an executive at Mueller Industries Inc., acquired 9,000 shares of common stock.
  • The acquisition was performance-based restricted stock.
  • The price per share was $0.
  • Following the transaction, Miritello directly owns 109,255 shares of Mueller Industries Inc.
  • The performance-based restricted stock may be earned between 0% and 200% of the target amount reported based on the Issuer's actual performance as compared with an adjusted EBITDA target during the three-year period from December 31, 2023 through December 26, 2026.
  • The vesting date is July 30, 2029.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard transaction filing, with a slightly positive undertone due to the executive increasing their stake in the company.

Positives

  • An executive increasing their holdings in the company can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The number of shares earned will depend on the company's performance against an adjusted EBITDA target over a three-year period, with potential to earn between 0% and 200% of the target amount.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the alignment of executive incentives with company performance.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company executive.

Key Dates

DateDescription
December 31, 2023Start date for the three-year period for adjusted EBITDA target calculation.
August 5, 2024Date of the stock acquisition.
August 6, 2024Date of signature by Attorney-in-Fact.
December 26, 2026End date for the three-year period for adjusted EBITDA target calculation.
July 30, 2029Vesting date for the performance-based restricted stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.